CIK 0001652935 · <br>Emerging growth company
ACTUATE THERAPEUTICS, INC.
Sign in to watch- Ticker
- ACTU
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 473044785
- Phone
- 847-986-4190
- Business address
- 1751 RIVER RUN, SUITE 400, FORT WORTH, TX, 76107
- Open-market buys, last 90 days
- $50,000
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$50,000. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-08-14 | THOMSON TODD S Director | Conversion | +138,889 | 138,889 | ||
| 2024-08-14 | THOMSON TODD S Director | Conversion | +230,597 | 230,597 | ||
| 2024-08-14 | THOMSON TODD S Director | Conversion | +132,908 | 271,797 | ||
| 2024-08-14 | THOMSON TODD S Director | Conversion | +24,138 | 254,735 | ||
| 2024-08-14 | THOMSON TODD S Director | Conversion | +49,984 | 321,781 | ||
| 2024-08-14 | THOMSON TODD S Director | Option exercise | +28,464 | $5.27 | $150K | 1,203,545 |
| 2024-08-14 | THOMSON TODD S Director | Sale | −18,750 | $8.00 | $150K | 1,184,795 |
| 2024-08-14 | THOMSON TODD S Director | Conversion · Series B-1 Redeemable Convertible Preferred Stock | +1,058,318 | 0 | ||
| 2024-08-14 | THOMSON TODD S Director | Conversion · Series B-2 Redeemable Convertible Preferred Stock | +726,163 | 0 | ||
| 2024-08-14 | THOMSON TODD S Director | Conversion · Series B-3 Redeemable Convertible Preferred Stock | +69,445 | 0 | ||
| 2024-08-14 | THOMSON TODD S Director | Conversion · Series B-3 Redeemable Convertible Preferred Stock | +146,870 | 0 | ||
| 2024-08-14 | THOMSON TODD S Director | Conversion · Series B-3 Redeemable Convertible Preferred Stock | +138,889 | 0 | ||
| 2024-08-14 | THOMSON TODD S Director | Conversion · Series B-4 Redeemable Convertible Preferred Stock | +230,597 | 0 | ||
| 2024-08-14 | THOMSON TODD S Director | Conversion · Series B-4 Redeemable Convertible Preferred Stock | +132,908 | 0 | ||
| 2024-08-14 | THOMSON TODD S Director | Conversion · Series C Redeemable Convertible Preferred Stock | +24,138 | 0 | ||
| 2024-08-14 | THOMSON TODD S Director | Conversion · Series C Redeemable Convertible Preferred Stock | +49,984 | 0 | ||
| 2024-08-14 | THOMSON TODD S Director | Option exercise · Warrant (Right to Buy) | +28,464 | 0 | ||
| 2024-08-14 | Bios Equity COF, LP Director | Conversion | +884,427 | 884,427 | ||
| 2024-08-14 | Bios Equity COF, LP Director | Purchase | +375,000 | $8.00 | $3.0M | 1,259,427 |
| 2024-08-14 | Bios Equity COF, LP Director | Purchase | +125,000 | $8.00 | $1.0M | 125,000 |
Page 5 of 14 · 272 trades